Page last updated: 2024-09-05

l 163191 and enalaprilat anhydrous

l 163191 has been researched along with enalaprilat anhydrous in 1 studies

Compound Research Comparison

Studies
(l 163191)
Trials
(l 163191)
Recent Studies (post-2010)
(l 163191)
Studies
(enalaprilat anhydrous)
Trials
(enalaprilat anhydrous)
Recent Studies (post-2010) (enalaprilat anhydrous)
3501784610976

Protein Interaction Comparison

ProteinTaxonomyl 163191 (IC50)enalaprilat anhydrous (IC50)
Angiotensin-converting enzymeMus musculus (house mouse)0.0115
Angiotensin-converting enzyme Homo sapiens (human)0.2405
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)0.0054
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.0012
Angiotensin-converting enzymeRattus norvegicus (Norway rat)0.0036
Angiotensin-converting enzyme 2 Homo sapiens (human)0.0024

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Patchett, AA1

Other Studies

1 other study(ies) available for l 163191 and enalaprilat anhydrous

ArticleYear
2002 Alfred Burger Award Address in Medicinal Chemistry. Natural products and design: interrelated approaches in drug discovery.
    Journal of medicinal chemistry, 2002, Dec-19, Volume: 45, Issue:26

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Awards and Prizes; Benzodiazepinones; Biological Products; Chemistry, Organic; Drug Design; History, 20th Century; History, 21st Century; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; United States

2002